Immatics (IMTX) Asset Utilization Ratio (2020 - 2026)
Immatics (IMTX) posted Asset Utilization Ratio of 0.09 for Q4 2025, down 41.32% sequentially from 0.15 in Q3 2025, and down 65.04% YoY from 0.24 in Q4 2024.
Analysis
Immatics (IMTX) Asset Utilization Ratio (2020 - 2026) Analysis & Trends
Immatics has reported Asset Utilization Ratio for 6 years, with the latest figure at 0.09 in Q4 2025.
- Quarterly Asset Utilization Ratio fell 65.04% year-over-year to 0.09 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.09 (down 65.04% YoY) and the FY2025 annual result came in at 0.08, down 69.62% from the prior year.
- Asset Utilization Ratio eased to 0.09 in Q4 2025 per IMTX's latest filing, from 0.15 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.57 in Q1 2022 and troughed at 0.09 in Q4 2025.
- A 5-year average of 0.23 and a median of 0.19 in 2021 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2022 and 2023: Asset Utilization Ratio jumped 355.42% in 2022, then sank 76.48% in 2023.
- Over 5 years, Asset Utilization Ratio stood at 0.19 in 2021, then soared by 158.28% to 0.48 in 2022, then tumbled by 76.48% to 0.11 in 2023, then surged by 114.76% to 0.24 in 2024, then tumbled by 65.04% to 0.09 in 2025.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.09, 0.15, and 0.21 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 0.20 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 0.69 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 0.90 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.13 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 0.54 |
| 10 | Immatics | 1.17 Bn | 711.21 Mn | - | 0.08 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.08 |
| Mar 31, 2026 | 0.07 |
| Dec 31, 2025 | 0.09 |
| Sep 30, 2025 | 0.15 |
| Jun 30, 2025 | 0.21 |
| Mar 31, 2025 | 0.22 |
| Dec 31, 2024 | 0.24 |
| Sep 30, 2024 | 0.19 |
| Jun 30, 2024 | 0.11 |
| Mar 31, 2024 | 0.13 |
| Dec 31, 2023 | 0.11 |
| Sep 30, 2023 | 0.17 |
| Jun 30, 2023 | 0.21 |
| Mar 31, 2023 | 0.20 |
| Dec 31, 2022 | 0.48 |
| Sep 30, 2022 | 0.45 |
| Jun 30, 2022 | 0.45 |
| Mar 31, 2022 | 0.57 |
| Dec 31, 2021 | 0.19 |
| Sep 30, 2021 | 0.14 |